Medicare Enrolled
Dr. Brian Wojciechowski, MD
Hematology & Oncology · Ridley Park, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wojciechowski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wojciechowski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wojciechowski
Dr. Brian Wojciechowski is a hematology & oncology specialist in Ridley Park, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Wojciechowski performed 44,605 Medicare services across 2,272 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wojciechowski received a total of $10,467 from 70 pharmaceutical and/or device companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wojciechowski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 13% volume in PA
$10,467 industry payments
Medicare Practice Summary
Medicare Utilization ↗44,605
Medicare services
Top 13% in PA for hematology & oncology
2,272
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,478 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
10,800 | $38 | $134 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
9,220 | $2 | $21 |
| Denosumab injection (Prolia/Xgeva) | 6,600 | $19 | $68 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
6,600 | $0 | $6 |
| Iron infusion (Monoferric) | 3,300 | $17 | $72 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,496 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,460 | $1 | $122 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
961 | $8 | $35 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
797 | $8 | $19 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
583 | $73 | $148 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
438 | $100 | $224 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
370 | $13 | $105 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
300 | $85 | $879 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
248 | $112 | $686 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
204 | $12 | $93 |
| Injection, granisetron hydrochloride, 100 mcg | 200 | $0 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
118 | $148 | $301 |
| New patient office visit, complex (60-74 min) | 117 | $180 | $432 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
107 | $25 | $152 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
101 | $63 | $205 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
80 | $24 | $156 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
75 | $142 | $414 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
69 | $55 | $304 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
64 | $56 | $334 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
60 | $1 | $7 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
49 | $1 | $9 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
37 | $18 | $97 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
37 | $42 | $115 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
30 | $80 | $251 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
23 | $10 | $73 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
23 | $2 | $19 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
20 | $20 | $111 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
18 | $26 | $249 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.7% high complexity
84.1% medium
7.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,467
Total received (2018-2024)
Avg $1,745/year across 6 years
Top 22% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
470
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,990 (85.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,478 (14.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,977
2023
$110
2021
$531
2020
$2,142
2019
$2,440
2018
$2,267
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$321
Janssen Biotech, Inc.
$266
AstraZeneca Pharmaceuticals LP
$196
Astellas Pharma US Inc
$174
ABBVIE INC.
$165
Takeda Pharmaceuticals U.S.A., Inc.
$165
Daiichi Sankyo Inc.
$157
GENZYME CORPORATION
$134
EMD Serono, Inc.
$120
Merck Sharp & Dohme LLC
$118
E.R. Squibb & Sons, L.L.C.
$108
Celgene Corporation
$87
ARRAY BIOPHARMA INC
$75
PFIZER INC.
$71
Incyte Corporation
$68
Genentech USA, Inc.
$62
Gilead Sciences, Inc.
$61
BeiGene USA, Inc.
$52
Stemline Therapeutics Inc.
$46
Alexion Pharmaceuticals, Inc.
$42
Rigel Pharmaceuticals, Inc.
$42
Blueprint Medicines Corporation
$37
Karyopharm Therapeutics Inc.
$34
Immunocore Limited
$32
Acrotech Biopharma Inc.
$31
SOBI, INC
$31
JAZZ PHARMACEUTICALS INC.
$29
Apellis Pharmaceuticals, Inc.
$28
Lilly USA, LLC
$25
Tempus AI, Inc
$24
Bayer Healthcare Pharmaceuticals Inc.
$24
GlaxoSmithKline, LLC.
$23
Eisai Inc.
$22
Mirati Therapeutics, Inc.
$21
Janssen Pharmaceuticals, Inc
$20
RECORDATI_RARE_DISEASES_INC.
$17
TAIHO ONCOLOGY, INC.
$17
Sumitomo Pharma America, Inc.
$16
Deciphera Pharmaceuticals Inc.
$16
Top 3 companies account for 26.3% of 2024 payments
All-time payments by company (2018-2024) ›
Rigel Pharmaceuticals, Inc.
$1,056
PFIZER INC.
$705
Novartis Pharmaceuticals Corporation
$679
Janssen Biotech, Inc.
$621
Genentech USA, Inc.
$549
Amgen Inc.
$505
AstraZeneca Pharmaceuticals LP
$492
E.R. Squibb & Sons, L.L.C.
$465
Celgene Corporation
$342
Incyte Corporation
$333
Lilly USA, LLC
$295
Daiichi Sankyo Inc.
$273
Astellas Pharma US Inc
$263
EMD Serono, Inc.
$256
Pharmacyclics LLC, An AbbVie Company
$237
Takeda Pharmaceuticals U.S.A., Inc.
$234
Janssen Pharmaceuticals, Inc
$217
Merck Sharp & Dohme Corporation
$205
GENZYME CORPORATION
$167
ABBVIE INC.
$165
Servier Pharmaceuticals LLC
$159
Bayer HealthCare Pharmaceuticals Inc.
$128
TESARO, Inc.
$126
Merck Sharp & Dohme LLC
$118
Eisai Inc.
$118
ARRAY BIOPHARMA INC
$114
Taiho Oncology, Inc.
$108
Gilead Sciences, Inc.
$102
Seagen Inc.
$100
Seattle Genetics, Inc.
$70
Exelixis Inc.
$69
Ipsen Biopharmaceuticals, Inc
$62
Clovis Oncology, Inc.
$60
Blueprint Medicines Corporation
$59
BeiGene USA, Inc.
$52
Mirati Therapeutics, Inc.
$50
Stemline Therapeutics Inc.
$46
EISAI INC.
$46
Alexion Pharmaceuticals, Inc.
$42
GlaxoSmithKline, LLC.
$40
Dendreon Pharmaceuticals LLC
$40
Kite Pharma, Inc.
$37
Puma Biotechnology, Inc.
$37
Secura Bio, Inc.
$36
Otsuka America Pharmaceutical, Inc.
$35
Karyopharm Therapeutics Inc.
$34
Foundation Medicine, Inc.
$33
AMAG Pharmaceuticals, Inc.
$33
Immunocore Limited
$32
Acrotech Biopharma Inc.
$31
SOBI, INC
$31
JAZZ PHARMACEUTICALS INC.
$29
Apellis Pharmaceuticals, Inc.
$28
Tempus AI, Inc
$24
INSYS Therapeutics Inc
$24
AbbVie, Inc.
$24
Bayer Healthcare Pharmaceuticals Inc.
$24
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
Global Blood Therapeutics, Inc.
$19
Spectrum Pharmaceuticals Inc.
$18
Jazz Pharmaceuticals Inc.
$17
RECORDATI_RARE_DISEASES_INC.
$17
TAIHO ONCOLOGY, INC.
$17
Sumitomo Pharma America, Inc.
$16
Deciphera Pharmaceuticals Inc.
$16
Mylan Institutional Inc.
$15
AbbVie Inc.
$14
Aurobindo Pharma USA, Inc.
$13
Janssen Scientific Affairs, LLC
$12
Advanced Accelerator Applications
$12
Top 3 companies account for 23.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BALVERSA · BELEODAQ · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CALQUENCE · CARVYKTI · CYRAMZA · Cabometyx · DARZALEX · ELIQUIS · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · Empaveli · Enhertu · Erleada · FARYDAK · FERAHEME · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Fulphila · GAZYVA · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idhifa · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MVASI · MYLOTARG · Marqibo · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Perjeta · Polivy · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNAGIS · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · Tavalisse · Tecentriq · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · Vanflyta · Venclexta · Vitrakvi · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONDELIS · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zevalin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
283
Per 100K population
49.1
County median income
$88,576
Nearest hospital
CROZER CHESTER MEDICAL CENTER
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wojciechowski is a mixed practice specialist, with above-average Medicare volume (top 13% in PA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wojciechowski experienced with daratumumab injection (darzalex)?
Based on Medicare claims data, Dr. Wojciechowski performed 10,800 daratumumab injection (darzalex) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wojciechowski receive payments from pharmaceutical companies?
Yes. Dr. Wojciechowski received a total of $10,467 from 70 companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wojciechowski's costs compare to other hematology & oncology specialists in Ridley Park?
Dr. Wojciechowski's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wojciechowski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Ridley Park
Browse hematology & oncology specialists in Ridley Park ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
Rigel Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Rigel Pharmaceuticals, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology